Innovation Award Submission

The KCHP Health-System Innovation Award is given annually by the KCHP Foundation. It is designated to recognize the demonstration of a program or process that improves patient care, services, or utilization of resources. Projects can be in a health system, inpatient, or ambulatory care pharmacy setting. Submissions may include improvements in either clinical or operational pharmacy practice activities.  Individuals and health systems are eligible for the award. KCHP strives to share innovative pharmacy practices that demonstrate improvement in patient care or pharmacy processes, examples of past submissions are available below.
The deadline for submissions is December 31, 2019 .  Please submit a summary or abstract (no more than two pages) of your innovative practice via the link below. One winner will be selected from all applications. The winner and first runner up will present their innovative practices at the KCHP 2020 Spring Meeting. 
Examples of Successful Past Submissions
Pharmacoeconomic Impact of an Alternative Workflow Process for Stroke (2019, Winner)

Brian Gilbert ( ) Wesley Medical Center

Wesley Medical Center (WMC) has implemented a process in which we utilize 50 mg vials of tPA in the AIS process. This allows for early bedside mixing of tPA for faster administration and the ability of the main central pharmacy to prepare the remaining dose and salvage waste. The initial bolus and initial infusion dose are prepared bedside utilizing a 50 mg/50 mL vial into a syringe. While the first 50 mg portion of the dose is being utilized at the bedside a second 50 mg vial is prepared under sterile conditions by the main central pharmacy and any excess waste is salvaged into 1 mg/mL aliquots to be utilized primarily for catheter clearance.
Pharmacy Concierge Services (2019)

Evan Williams ( ), The University of Kansas Health System

The vision for this service at our organization was to go beyond bedside medication delivery to encompass all the post-discharge medication needs and preferences the patient has, which is why the name Pharmacy Concierge Service (PCS) was chosen. 
Removal of Emergency Department Medication Order Auto-verification (2019)

Lucy Stun ( ), The University of Kansas Health System

The pharmacy department at University of Kansas Health System (TUKHS) performed a review of the 2015 safety events in the ED and saw that a majority of our medication safety events were due to over-dosing, under-dosing and duplicate administration of medications. Upon further evaluation it was noted that 72% were antimicrobial related, 17% were anticoagulant related and 11% were categorized as ‘other’. This data combined with newly implemented 24/7 ED pharmacy support led the charge to remove auto-verification in the ED at TUKHS.
Development of a successful immune effector cell therapy program at an academic medical center: the role of the pharmacist (2019)

Zahra Mahmoudjafari ( ), The University of Kansas Health System

Chimeric antigen receptor T cell (CAR T) therapy is a form of immune effector cell therapy utilizing patients’ T cells through an adoptive cell transfer process to create antitumor activity.1 As of October 2017, two products, tisgenlecleucel and axicabtagene ciloleucel are approved by the Food and Drug Administration (FDA) to treat certain types of leukemia and lymphoma and the University of Kansas Health System is accredited to provide both treatments2,3 The FDA requires compliance with the Risk Evaluation and Mitigation Strategy (REMS) for treatment centers to be authorized to administer these products. This innovative therapy was first of its kind and required centers to develop robust practices to support successful treatment of patients. Our program was the third institution in the country to complete all requirements to administer axicabtagene ciloleucel commercially.
Kansas Council of Health-System Pharmacy (KCHP)
p: 314-416-2247 | f: 314-892-1891 | E: |